• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Delta-24-RGD对脑肿瘤干细胞的治疗潜力研究:自噬性细胞死亡的作用

Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death.

作者信息

Jiang Hong, Gomez-Manzano Candelaria, Aoki Hiroshi, Alonso Marta M, Kondo Seiji, McCormick Frank, Xu Jing, Kondo Yasuko, Bekele B Nebiyou, Colman Howard, Lang Frederick F, Fueyo Juan

机构信息

Brain Tumor Center, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

出版信息

J Natl Cancer Inst. 2007 Sep 19;99(18):1410-4. doi: 10.1093/jnci/djm102. Epub 2007 Sep 11.

DOI:10.1093/jnci/djm102
PMID:17848677
Abstract

The eradication of brain tumor stem cells is essential for long-term brain tumor remission after treatment. In this study, we examined the therapeutic potential of an oncolytic adenovirus, Delta-24-RGD, targeted to the abnormal p16INK4/Rb pathway in brain tumor stem cells. Four brain tumor stem cell lines from surgical glioblastoma specimens expressed high levels of adenoviral receptors and allowed for efficient viral infection, replication, and oncolysis in an Rb-dependent manner. Delta-24-RGD induced autophagic cell death, as indicated by accumulation of Atg5 and LC3-II protein and autophagic vacuoles. Treatment of xenografts derived from brain tumor stem cells with Delta-24-RGD statistically significantly improved the survival of glioma-bearing mice (means: 38.5 versus 66.3 days, difference = 27.8 days, 95% confidence interval = 19.5 to 35.9 days, P <.001). Analyses of treated tumors showed that Atg5 expression colocalized with viral fiber protein and delineated a wave front of autophagic cells that circumscribed areas of virally induced necrosis. Our results show for the first time that brain tumor stem cells are susceptible to adenovirus-mediated cell death via autophagy in vitro and in vivo.

摘要

根除脑肿瘤干细胞对于治疗后实现脑肿瘤的长期缓解至关重要。在本研究中,我们检测了一种溶瘤腺病毒Delta-24-RGD针对脑肿瘤干细胞中异常的p16INK4/Rb通路的治疗潜力。来自手术切除的胶质母细胞瘤标本的四种脑肿瘤干细胞系表达高水平的腺病毒受体,并允许以Rb依赖的方式进行有效的病毒感染、复制和溶瘤。Delta-24-RGD诱导自噬性细胞死亡,表现为Atg5和LC3-II蛋白以及自噬泡的积累。用Delta-24-RGD处理源自脑肿瘤干细胞的异种移植瘤,在统计学上显著提高了荷胶质瘤小鼠的生存率(平均值:38.5天对66.3天,差异=27.8天,95%置信区间=19.5至35.9天,P<.001)。对治疗后的肿瘤分析表明,Atg5表达与病毒纤维蛋白共定位,并勾勒出一个自噬细胞的波前,该波前围绕着病毒诱导坏死的区域。我们的结果首次表明,脑肿瘤干细胞在体外和体内均易受腺病毒介导的通过自噬的细胞死亡的影响。

相似文献

1
Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death.Delta-24-RGD对脑肿瘤干细胞的治疗潜力研究:自噬性细胞死亡的作用
J Natl Cancer Inst. 2007 Sep 19;99(18):1410-4. doi: 10.1093/jnci/djm102. Epub 2007 Sep 11.
2
The HDAC Inhibitors Scriptaid and LBH589 Combined with the Oncolytic Virus Delta24-RGD Exert Enhanced Anti-Tumor Efficacy in Patient-Derived Glioblastoma Cells.组蛋白去乙酰化酶抑制剂Scriptaid和LBH589与溶瘤病毒Delta24-RGD联合应用对患者来源的胶质母细胞瘤细胞具有增强的抗肿瘤疗效。
PLoS One. 2015 May 18;10(5):e0127058. doi: 10.1371/journal.pone.0127058. eCollection 2015.
3
Delta-24-RGD in combination with RAD001 induces enhanced anti-glioma effect via autophagic cell death.Delta-24-RGD与RAD001联合使用可通过自噬性细胞死亡诱导增强的抗胶质瘤效应。
Mol Ther. 2008 Mar;16(3):487-93. doi: 10.1038/sj.mt.6300400. Epub 2008 Feb 5.
4
Targeting brain tumor stem cells with oncolytic adenoviruses.用溶瘤腺病毒靶向脑肿瘤干细胞。
Methods Mol Biol. 2012;797:111-25. doi: 10.1007/978-1-61779-340-0_9.
5
Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway.靶向视网膜母细胞瘤通路的趋化性增强腺病毒抗胶质瘤活性的临床前特征分析
J Natl Cancer Inst. 2003 May 7;95(9):652-60. doi: 10.1093/jnci/95.9.652.
6
Tamoxifen improves cytopathic effect of oncolytic adenovirus in primary glioblastoma cells mediated through autophagy.他莫昔芬可改善溶瘤腺病毒在原发性胶质母细胞瘤细胞中通过自噬介导的细胞病变效应。
Oncotarget. 2015 Feb 28;6(6):3977-87. doi: 10.18632/oncotarget.2897.
7
Autophagy-inducing agents augment the antitumor effect of telerase-selve oncolytic adenovirus OBP-405 on glioblastoma cells.自噬诱导剂增强端粒酶-溶瘤腺病毒OBP-405对胶质母细胞瘤细胞的抗肿瘤作用。
Gene Ther. 2008 Sep;15(17):1233-9. doi: 10.1038/gt.2008.98. Epub 2008 Jun 26.
8
Combination treatment for glioblastoma cells with tumor necrosis factor-related apoptosis-inducing ligand and oncolytic adenovirus delta-24.联合使用肿瘤坏死因子相关凋亡诱导配体和溶瘤腺病毒 delta-24 治疗神经胶质瘤细胞。
Cancer Invest. 2013 Nov;31(9):630-8. doi: 10.3109/07357907.2013.849724.
9
Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma.存活素驱动且纤维修饰的溶瘤腺病毒在已形成的颅内胶质瘤中展现出强大的抗肿瘤活性。
Hum Gene Ther. 2007 Jul;18(7):589-602. doi: 10.1089/hum.2007.002.
10
Oncolytic adenovirus retargeted to Delta-EGFR induces selective antiglioma activity.靶向Delta-EGFR的溶瘤腺病毒诱导选择性抗胶质瘤活性。
Cancer Gene Ther. 2009 Mar;16(3):256-65. doi: 10.1038/cgt.2008.75. Epub 2008 Oct 17.

引用本文的文献

1
Cancer Stem Cells Connecting to Immunotherapy: Key Insights, Challenges, and Potential Treatment Opportunities.癌症干细胞与免疫疗法的关联:关键见解、挑战及潜在治疗机遇
Cancers (Basel). 2025 Jun 23;17(13):2100. doi: 10.3390/cancers17132100.
2
Autophagy and Respiratory Viruses: Mechanisms, Viral Exploitation, and Therapeutic Insights.自噬与呼吸道病毒:机制、病毒利用及治疗见解
Cells. 2025 Mar 12;14(6):418. doi: 10.3390/cells14060418.
3
Oncolytic Adenovirus for the Targeting of Paclitaxel-Resistant Breast Cancer Stem Cells.用于靶向紫杉醇耐药乳腺癌干细胞的溶瘤腺病毒
Viruses. 2024 Apr 5;16(4):567. doi: 10.3390/v16040567.
4
New Salicylanilide Derivatives and Their Peptide Conjugates as Anticancer Compounds: Synthesis, Characterization, and Effect on Glioblastoma.新型水杨酰苯胺衍生物及其肽缀合物作为抗癌化合物:合成、表征及对胶质母细胞瘤的作用
ACS Omega. 2024 Apr 5;9(15):16927-16948. doi: 10.1021/acsomega.3c05727. eCollection 2024 Apr 16.
5
Gut microbiota composition is associated with the efficacy of Delta-24-RGDOX in malignant gliomas.肠道微生物群组成与Delta-24-RGDOX在恶性胶质瘤中的疗效相关。
Mol Ther Oncol. 2024 Feb 28;32(1):200787. doi: 10.1016/j.omton.2024.200787. eCollection 2024 Mar 21.
6
Chimeric oncolytic adenovirus evades neutralizing antibodies from human patients and exhibits enhanced anti-glioma efficacy in immunized mice.嵌合溶瘤腺病毒可逃避人类患者的中和抗体,并在免疫小鼠中表现出增强的抗胶质瘤疗效。
Mol Ther. 2024 Mar 6;32(3):722-733. doi: 10.1016/j.ymthe.2024.01.035. Epub 2024 Feb 3.
7
Novel Therapies in Glioblastoma Treatment: Review of Glioblastoma; Current Treatment Options; and Novel Oncolytic Viral Therapies.新型疗法治疗胶质母细胞瘤:胶质母细胞瘤综述;当前治疗选择;新型溶瘤病毒疗法。
Med Sci (Basel). 2023 Dec 23;12(1):1. doi: 10.3390/medsci12010001.
8
Neuronal differentiation drives the antitumor activity of mitogen-activated protein kinase kinase (MEK) inhibition in glioblastoma.神经元分化驱动丝裂原活化蛋白激酶激酶(MEK)抑制在胶质母细胞瘤中的抗肿瘤活性。
Neurooncol Adv. 2023 Oct 12;5(1):vdad132. doi: 10.1093/noajnl/vdad132. eCollection 2023 Jan-Dec.
9
Advances in oncolytic herpes simplex virus and adenovirus therapy for recurrent glioma.溶瘤单纯疱疹病毒和腺病毒治疗复发性脑胶质瘤的研究进展。
Front Immunol. 2023 Nov 2;14:1285113. doi: 10.3389/fimmu.2023.1285113. eCollection 2023.
10
p53-armed oncolytic adenovirus induces autophagy and apoptosis in KRAS and BRAF-mutant colorectal cancer cells.p53 武装溶瘤腺病毒诱导 KRAS 和 BRAF 突变结直肠癌细胞自噬和凋亡。
PLoS One. 2023 Nov 16;18(11):e0294491. doi: 10.1371/journal.pone.0294491. eCollection 2023.